BOSTON - TelAve -- ClaraWell Inc. announced the completion of the ClaraWell Health Network's public deployment phase, concluding active operation of ten topic-specific AI health applications developed to provide accessible, privacy-respecting, and carefully bounded health information experiences.

Beginning with early prototypes in March 2025, the ClaraWell Health Network progressed through a series of public deployments covering common health topics including flu, cough, fever, headache, allergies, sinus concerns, snoring, insomnia, heartburn, and sore throat.

The applications operated as focused public health surfaces without persistent user accounts or retained clinical records. Across the network, ClaraWell developed and operated structured health information, conversational access, stateless architecture, deterministic governance, privacy controls, and clearly defined non-diagnostic boundaries.

More on TelAve News

• ChargeOn Announces Conversational Payment Management Solution
• King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
• Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center
• Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
• As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms

The ClaraWell Health Network has now completed its intended deployment period, establishing a durable operating foundation for ClaraWell's broader work in governed health AI.

ClaraWell also recognizes Microsoft for its support through Microsoft for Startups during a formative period of the company's development. That support provided valuable infrastructure as the ClaraWell Health Network progressed from early experimentation to completed public deployments. ClaraWell is grateful for Microsoft's role during that phase.

With this development phase complete, ClaraWell's public presence is now centered at ClaraWell.com.

Learn more about ClaraWell at https://clarawell.com